NCT06809686Recruiting
Study to Collect High-Resolution ECG Data and Patient Insights on Heart Failure Care
An Observational Study to Collect High Resolution 12-Lead Electrocardiogram (ECG) Data for the Development of an ECG Library to Support the Development of a Tool to Monitor Disease Progression, Gather Patient Perspectives on Standard of Care Heart Failure Procedures and Facilitate Familiarity With the Clinical Trial Environment in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction
Source: ClinicalTrials.gov · Last updated 20 May 2026
Brief summary (registry, in English)
The purpose of this study is to establish an electrocardiogram (ECG) data library to facilitate future studies on heart disease. Additionally, the study will be used to monitor changes in the patient's standard of care throughout the study period and gather patient perspectives on routine diagnostic procedures and disease monitoring and feedback on the design of heart failure trials.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 30 Jan 2025
- Start date
- 5 Feb 2025
- Primary completion date
- 21 Jan 2027
- Lead sponsor
- Richmond Research Institute
- Diseases
- Heart failure
- NCT number
- NCT06809686
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 5 Feb 2025 to the primary completion date, 21 Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Diagnostic test results positive for:
- HIV-1 or HIV-2 infection
- Hepatitis B or Hepatitis C infection
- Any condition judged by the Investigator to pose an undue risk while participating in the trial
Lab values
- Diagnostic results which are inconsistent with heart failure with mildly reduced or preserved ejection fraction as judged by the Investigator.
Other
- Mental incapacity, language barriers or unwillingness to comply with the requirements of the protocol, which may preclude adequate understanding or cooperation during the study as judged by the Investigator.
Who the study is looking for
- Male or female participants aged 45 to 80 years (inclusive) at the date of signing the informed consent.
- Diagnosed with heart failure.
- Able and willing to provide informed consent to participate.
Age in the registry: 45 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Richmond Pharmacology Coordinator of this site? Confirm its status | London | United Kingdom | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.